{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:12:48Z","timestamp":1789906368063,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.virusres.2018.07.004","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T13:02:40Z","timestamp":1531141360000},"page":"77-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients"],"prefix":"10.1016","volume":"255","author":[{"given":"Noha Mohamed Hosni","family":"Shaheen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermine Magdi","family":"Riad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend H.","family":"Tamim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha Mohamed Hosny","family":"Shahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia A.","family":"Labib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan Mahrous","family":"ELsheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham Abdel","family":"Moneim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Yosry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania H","family":"khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2018.07.004_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7150\/jca.3.19","article-title":"Promising candidate urinary microRNA biomarkers for the early detection of hepatocellular carcinoma among high-risk hepatitis C virus Egyptian patients","volume":"3","author":"Abdalla","year":"2012","journal-title":"J Cancer"},{"issue":"46","key":"10.1016\/j.virusres.2018.07.004_bib0010","doi-asserted-by":"crossref","first-page":"32015","DOI":"10.1074\/jbc.M109.016774","article-title":"MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib","volume":"284","author":"Bai","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.virusres.2018.07.004_bib0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.virusres.2018.07.004_bib0020","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ejca.2013.12.024","article-title":"miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1","volume":"50","author":"Cao","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.virusres.2018.07.004_bib0025","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1007\/s13277-015-3430-2","article-title":"Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma","volume":"36","author":"Chen","year":"2015","journal-title":"Tumour Biol."},{"issue":"9","key":"10.1016\/j.virusres.2018.07.004_bib0030","first-page":"645","article-title":"Evaluation of miR-182\/miR-100 ratio for diagnosis and survival prediction in bladder cancer","volume":"19","author":"Chen","year":"2016","journal-title":"Arch. Iran. Med."},{"issue":"15","key":"10.1016\/j.virusres.2018.07.004_bib0035","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s00018-012-0940-6","article-title":"Let-7b is a novel regulator of hepatitis C virus replication","volume":"69","author":"Cheng","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"issue":"21","key":"10.1016\/j.virusres.2018.07.004_bib0040","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.3748\/wjg.v23.i21.3864","article-title":"Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients","volume":"23","author":"Elemeery","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.virusres.2018.07.004_bib0045","series-title":"Egypt Demographic and Health Survey 2008","author":"El\u2010Zanaty","year":"2009"},{"issue":"11","key":"10.1016\/j.virusres.2018.07.004_bib0050","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1128\/JVI.00016-14","article-title":"Reduction of microRNA 122 expression in IFNL3 CT\/TT carriers and during progression of fibrosis in patients with chronic hepatitis C","volume":"88","author":"Estrabaud","year":"2014","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virusres.2018.07.004_bib0055","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/jcmm.12398","article-title":"miR-150 functions as a tumour suppressor in human colorectal cancer by targeting c-Myb","volume":"18","author":"Feng","year":"2014","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.virusres.2018.07.004_bib0060","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/hep.26095","article-title":"MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?","volume":"57","author":"Giordano","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.07.004_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090929","article-title":"Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt","volume":"9","author":"Gomaa","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2018.07.004_bib0070","doi-asserted-by":"crossref","first-page":"437971","DOI":"10.1155\/2014\/437971","article-title":"Cancer incidence in Egypt: results of the national population-based cancer registry program","volume":"2014","author":"Ibrahim","year":"2014","journal-title":"J Cancer Epidemiol"},{"issue":"8","key":"10.1016\/j.virusres.2018.07.004_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103965","article-title":"MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1","volume":"9","author":"Jin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2018.07.004_bib0080","series-title":"Robbins & Cotran Pathologic Basis of Disease","first-page":"870","author":"Kumar","year":"2015"},{"issue":"10","key":"10.1016\/j.virusres.2018.07.004_bib0085","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/onc.2013.65","article-title":"Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis","volume":"33","author":"Lei","year":"2014","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.virusres.2018.07.004_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115577","article-title":"miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.virusres.2018.07.004_bib0095","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00384-013-1674-0","article-title":"Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value","volume":"28","author":"Liu","year":"2013","journal-title":"Int. J. Colorectal Dis."},{"issue":"4","key":"10.1016\/j.virusres.2018.07.004_bib0100","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"Llovet","year":"2012","journal-title":"J. Hepatol."},{"issue":"321","key":"10.1016\/j.virusres.2018.07.004_bib0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature10888","article-title":"The microcosmos of cancer","volume":"482","author":"Lujambio","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.virusres.2018.07.004_bib0110","first-page":"447","article-title":"HCV and associated concomitant infections at Sharkia Governorate, Egypt","volume":"34","author":"Mangoud","year":"2004","journal-title":"Journal of the Egyptian Society for Parasitology"},{"issue":"5","key":"10.1016\/j.virusres.2018.07.004_bib0115","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.gde.2005.08.005","article-title":"How microRNAs control cell division, differentiation and death","volume":"15","author":"Miska","year":"2005","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"4","key":"10.1016\/j.virusres.2018.07.004_bib0120","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"issue":"39","key":"10.1016\/j.virusres.2018.07.004_bib0125","doi-asserted-by":"crossref","first-page":"14381","DOI":"10.3748\/wjg.v20.i39.14381","article-title":"Recent advances in the surgical treatment of hepatocellular carcinoma","volume":"20","author":"Morise","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"14","key":"10.1016\/j.virusres.2018.07.004_bib0130","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1128\/JVI.00787-14","article-title":"Transcriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expression","volume":"88","author":"Mukherjee","year":"2014","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2018.07.004_bib0135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/hep.26616","article-title":"MicroRNA\/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC)","volume":"59","author":"Petrelli","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.virusres.2018.07.004_bib0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1590\/0037-8682-0416-2016","article-title":"Circulating microRNA as a marker for predicting liver disease progression in patients with chronic hepatitis B","volume":"50","author":"Riazalhosseini","year":"2017","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"17","key":"10.1016\/j.virusres.2018.07.004_bib0145","doi-asserted-by":"crossref","first-page":"7716","DOI":"10.1093\/nar\/gkr426","article-title":"miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components","volume":"39","author":"Roberts","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.virusres.2018.07.004_bib0150","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/cncr.29936","article-title":"Annual report to the nation on the Status of cancer, 1975-2012, featuring the increasing incidence of liver cancer","volume":"122","author":"Ryerson","year":"2016","journal-title":"Cancer"},{"issue":"28","key":"10.1016\/j.virusres.2018.07.004_bib0155","doi-asserted-by":"crossref","first-page":"25093","DOI":"10.18632\/oncotarget.4437","article-title":"Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance","volume":"6","author":"Shi","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.virusres.2018.07.004_bib0160","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.26296","article-title":"Upregulation of circulating miR-20a is correlated with hepatitis C virus mediated liver disease progression","volume":"58","author":"Shrivastava","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.07.004_bib0165","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/srep01555","article-title":"Circulating miRNA profile in HCV infected serum: novel insight into pathogenesis","volume":"3","author":"Shwetha","year":"2013","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.virusres.2018.07.004_bib0170","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1158\/0008-5472.CAN-08-2886","article-title":"MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity","volume":"69","author":"Su","year":"2009","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.virusres.2018.07.004_bib0175","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/jvh.12001","article-title":"Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122","volume":"20","author":"van der Meer","year":"2013","journal-title":"J. Viral Hepat."},{"issue":"3","key":"10.1016\/j.virusres.2018.07.004_bib0180","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/liv.12919","article-title":"microRNA changes in liver tissue associated with fibrosis progression in patients with hepatitis C","volume":"36","author":"Van Keuren-Jensen","year":"2016","journal-title":"Liver Int."},{"key":"10.1016\/j.virusres.2018.07.004_bib0185","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1471-2407-12-227","article-title":"MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma","volume":"12","author":"Wang","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.virusres.2018.07.004_bib0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13000-015-0369-y","article-title":"microRNA-150: apromising novel biomarker for hepatitis B virus-related hepatocellularcarcinoma","volume":"10","author":"Yu","year":"2015","journal-title":"Diagn. Pathol."},{"issue":"10","key":"10.1016\/j.virusres.2018.07.004_bib0195","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s11427-012-4384-x","article-title":"The role and clinical implications of microRNAs in hepatocellular carcinoma","volume":"55","author":"Zhao","year":"2012","journal-title":"Sci China Life Sci"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170218302296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170218302296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T14:43:49Z","timestamp":1568990629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170218302296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":39,"alternative-id":["S0168170218302296"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2018.07.004","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2018.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}